PRP and Ozone Injections Show Promise for Knee Arthritis Pain Relief

A completed clinical trial investigated two promising regenerative therapies for knee osteoarthritis, comparing platelet-rich plasma (PRP) injections with ozone therapy in 54 participants. The study addressed a critical need for effective treatments in mild to moderate knee arthritis, where joint cartilage remains salvageable.

The trial ran from August to October 2024 at Sisli Hamidiye Etfal Training and Research Hospital, focusing on patients whose knee pain persisted despite conventional treatments like physical therapy, medications, and hot/cold applications. Researchers specifically targeted cases where the joint cartilage was still partially or completely intact, making regenerative approaches more viable than in advanced arthritis.

PRP therapy involves extracting the patient's blood, concentrating the platelets, and injecting this platelet-rich solution directly into the affected knee joint. The concentrated platelets release growth factors that promote tissue repair and reduce inflammation. Ozone therapy delivers therapeutic oxygen molecules to the joint space, aiming to reduce inflammation and stimulate healing processes.

Both treatments represent alternatives to steroid injections, which may provide temporary relief but don't address underlying tissue damage. The study measured clinical outcomes including pain levels, joint function, and mobility improvements to determine which approach offers superior benefits.

For longevity-focused individuals, this research highlights the potential of regenerative medicine to maintain joint health and mobility as we age. Knee osteoarthritis commonly develops with advancing age and can significantly impact quality of life and physical activity levels. Effective regenerative treatments could help people maintain active lifestyles longer, supporting overall healthspan and independence in later years.